Tech Company Financing Transactions

Septerna Funding Round

RA Capital Management, BVF Partners and Catalio Capital Management participated in a $150 million Series B venture round for Septerna. This venture round closed on 7/12/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

250 East Grand Ave. 65
San Francisco, CA 94080
USA

Phone

650-338-3533

Website

www.septerna.com

Email Address

[email protected]

Overview

Our mission is to discover, develop, and commercialize medicines that improve the lives of patients by combining the potential of high-value GPCR drug targets with the power of state-of-the-art small molecule drug discovery technologies. Septerna's Native Complex Platform is the engine that will make this happen, moving ideas for disease-modifying therapies from possibility to reality.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Finer

        

Chief Medical Officer

Alan Ezekowitz

        

Chief Operating Officer

Dodzie Sogah

        

Vice President

Chris Heise

        

Vice President

Uwe Klein

        

Vice President

Daniel Long

        

Vice President

Amer Mirza

        

VP - Bus. Development

George Xu

        

VP - Engineering

Richard Hansen

        

VP - Human Resources

Kara Halvorsen

        

Browse more venture capital transactions:

Prev: 7/12/2023: SMART Photonics venture capital transaction
Next: 7/12/2023: Fold Health venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary